Your browser doesn't support javascript.
loading
Economic Impact of Insufficient and Disturbed Sleep in the Workplace.
Glick, Danielle R; Abariga, Samuel A; Thomas, Irine; Shipper, Andrea G; Gunia, Brian C; Grandner, Michael A; Rosenberg, Elliot; Hines, Stella E; Capaldi, Vincent; Collen, Jacob; Wickwire, Emerson M.
Afiliação
  • Glick DR; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sleep Disorders Center, University of Maryland School of Medicine, 100 N Greene St, 2nd Floor, Baltimore, MD, 21201, USA. danielle.glick@som.umaryland.edu.
  • Abariga SA; Department of Epidemiology & Biostatistics, School of Public Health, SUNY Downstate Health Sciences University, New York, NY, USA.
  • Thomas I; University of Maryland School of Medicine, Baltimore, MD, USA.
  • Shipper AG; Health Sciences and Human Services Library, University of Maryland, Baltimore, MD, USA.
  • Gunia BC; Charles Library, Temple University, Philadelphia, PA, USA.
  • Grandner MA; Carey Business School, Johns Hopkins University, Baltimore, MD, USA.
  • Rosenberg E; Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson, Tucson, AZ, USA.
  • Hines SE; School of Public Health, University of Haifa, Haifa, Israel.
  • Capaldi V; Division of Occupational and Environmental Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Collen J; Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
  • Wickwire EM; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Pharmacoeconomics ; 41(7): 771-785, 2023 07.
Article em En | MEDLINE | ID: mdl-36933184
OBJECTIVE: Insufficient and disturbed sleep are associated with significant morbidity among working-age adults. Poor sleep results in negative health outcomes and increases economic costs to employers. The current systematic review surveyed the peer-reviewed scientific literature and aggregated scientific evidence of sleep-related economic burdens borne by employers. METHODS: A systematic review was performed to identify peer-reviewed, English language studies evaluating the economic impact of insufficient and disturbed sleep among adult employee populations. An exhaustive literature search was performed using keywords related to sleep, economics, and the workplace. Included were scientific studies (randomized controlled trials, cohort and case control studies, cross-sectional and longitudinal studies) examining specific employee populations with relevant sleep and economic outcomes. Each included study was evaluated for risk of bias and relevant data was extracted and summarized. RESULTS: Sleep problems among employee populations are associated with worsened workplace outcomes, such as presenteeism, absenteeism, and accidents. Sleep problems also increased costs to employers, ranging from US$322 to US$1967 per employee. Interventions to improve sleep, such as the use of blue-light filtering glasses, strategic shift scheduling, and targeted interventions to treat insomnia, may improve workplace outcomes and reduce costs. CONCLUSIONS: This review synthesizes the existing data regarding the negative impacts of insufficient and disturbed sleep on the workplace, suggesting that employers have an economic stake in their employees' sleep. TRIAL REGISTRATION: PROSPERO: CRD42021224212.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Sono-Vigília / Local de Trabalho Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Sono-Vigília / Local de Trabalho Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
...